DNMT3A and leukemia: To further assess the ability of DNMT3A-corrected cells to initiate leukemia, we determined the leukemia-initiating cell (LIC) frequency from two patient samples by performing limiting dilution transplantation assays with re-mutated or corrected leukemic blasts (Figure 2J).